Diclofenac Diethylamine Topical Gel/Emulsion Suppliers & Bulk Manufacturers
Available Forms: Topical Gel/Emulsion
Available Strengths: 1%, 2%
Reference Brands: Voltaren Emulgel, Pennsaid(US)
Category:
Analgesic
Diclofenac Diethylamine topical gel inhibits cyclooxygenase enzymes (COX-1 and COX-2), reducing prostaglandin synthesis responsible for pain and inflammation. Benefits include targeted pain relief, rapid onset, fewer systemic side effects, and improved joint mobility. Ideal for localized musculoskeletal conditions with convenient, non-invasive application.
Diclofenac Diethylamine Topical Gel/Emulsion is available in Topical Gel/Emulsion
and strengths such as 1%, 2%.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Diclofenac Diethylamine Topical Gel/Emulsion is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Diclofenac Diethylamine Topical Gel/Emulsion can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Diclofenac Diethylamine topical gel/emulsion is approved in both the EU and US for localized musculoskeletal pain and inflammation. In the EU, brands like Voltaren are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data, pharmacovigilance, and quality assurance. Both regions enforce strict regulations, including proper labeling, usage guidelines, and monitoring for adverse effects. For expert guidance on regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access for diclofenac diethylamine gel/emulsion, ensuring adherence to European and US standards for safe, effective local anti-inflammatory therapy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing